Itau Unibanco Holding S.A.’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.1K | Sell |
122
-58
| -32% | -$10.9K | ﹤0.01% | 313 |
|
|
2026
Q1 | $35.5K | Sell |
180
-434
| -71% | -$83.7K | ﹤0.01% | 263 |
|
|
2025
Q4 | $113K | Sell |
614
-1,950
| -76% | -$342K | ﹤0.01% | 200 |
|
|
2025
Q3 | $393K | Sell |
2,564
-1,127
| -31% | -$171K | 0.01% | 156 |
|
|
2025
Q2 | $516K | Buy |
3,691
+162
| +5% | +$22.7K | 0.02% | 150 |
|
|
2025
Q1 | $519K | Sell |
3,529
-10,652
| -75% | -$1.54M | 0.02% | 158 |
|
|
2024
Q4 | $1.86M | Buy |
14,181
+6,034
| +74% | +$845K | 0.06% | 96 |
|
|
2024
Q3 | $1.27M | Buy |
8,147
+4,418
| +118% | +$713K | 0.04% | 106 |
|
|
2024
Q2 | $582K | Sell |
3,729
-6,109
| -62% | -$919K | 0.02% | 119 |
|
|
2024
Q1 | $1.33M | Buy |
9,838
+1,653
| +20% | +$219K | 0.06% | 71 |
|
|
2023
Q4 | $1.1M | Buy |
8,185
+3,108
| +61% | +$404K | 0.04% | 113 |
|
|
2023
Q3 | $688K | Sell |
5,077
-5,531
| -52% | -$755K | 0.03% | 113 |
|
|
2023
Q2 | $1.52M | Sell |
10,608
-123
| -1% | -$18.1K | 0.07% | 104 |
|
|
2023
Q1 | $1.49M | Buy |
10,731
+2,197
| +26% | +$296K | 0.07% | 93 |
|
|
2022
Q4 | $1.16M | Sell |
8,534
-1,997
| -19% | -$250K | 0.05% | 112 |
|
|
2022
Q3 | $1.16M | Sell |
10,531
-28,611
| -73% | -$3.63M | 0.05% | 108 |
|
|
2022
Q2 | $5.17M | Buy |
39,142
+16,205
| +71% | +$2.13M | 0.18% | 75 |
|
|
2022
Q1 | $3.04M | Sell |
22,937
-13,885
| -38% | -$1.67M | 0.08% | 90 |
|
|
2021
Q4 | $4.29M | Buy |
36,822
+20,003
| +119% | +$2.35M | 0.13% | 76 |
|
|
2021
Q3 | $2.02M | Buy |
16,819
+2,827
| +20% | +$329K | 0.11% | 96 |
|
|
2021
Q2 | $1.68M | Sell |
13,992
-3,889
| -22% | -$427K | 0.08% | 96 |
|
|
2021
Q1 | $1.78M | Buy |
17,881
+11,340
| +173% | +$1.14M | 0.13% | 86 |
|
|
2020
Q4 | $654K | Buy |
6,541
+5,104
| +355% | +$541K | 0.03% | 132 |
|
|
2020
Q3 | $157K | Buy |
+1,437
| New | +$160K | 0.01% | 145 |
|
|
2019
Q4 | – | Sell |
-5,199
| Closed | -$427K | – | 890 |
|
|
2019
Q3 | $427K | Hold |
5,199
| – | – | 0.02% | 120 |
|
|
2019
Q2 | $427K | Sell |
5,199
-2,107
| -29% | -$165K | 0.02% | 340 |
|
|
2019
Q1 | $541K | Hold |
7,306
| – | – | 0.02% | 104 |
|
|
2018
Q4 | $541K | Buy |
7,306
+151
| +2% | +$11.8K | 0.02% | 104 |
|
|
2018
Q3 | $566K | Sell |
7,155
-295
| -4% | -$22.3K | 0.03% | 107 |
|
|
2018
Q2 | $522K | Buy |
7,450
+1,947
| +35% | +$140K | 0.06% | 100 |
|
|
2018
Q1 | $385K | Buy |
5,503
+4,024
| +272% | +$279K | ﹤0.01% | 255 |
|
|
2017
Q4 | $103K | Buy |
1,479
+270
| +22% | +$18.2K | 0.01% | 361 |
|
|
2017
Q3 | $260K | Sell |
1,209
-2,953
| -71% | -$187K | 0.02% | 421 |
|
|
2017
Q2 | $284K | Buy |
4,162
+3,746
| +900% | +$245K | 0.03% | 161 |
|
|
2017
Q1 | $26K | Buy |
+416
| New | +$24.2K | ﹤0.01% | 346 |
|
Other funds holding AZN
EP
IA
Itau Unibanco Holding S.A.'s AZN Position: Q2 2026 in Review
Itau Unibanco Holding S.A. reduced its AstraZeneca (AZN) stake by 32% in Q2 2026, selling an estimated $10.9K and leaving 122 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #313.
Itau Unibanco Holding S.A. first reported a position in AZN in Q1 2017 and has held it in 35 quarters since. The position peaked at $5.17M in Q2 2022. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Itau Unibanco Holding S.A. held 122 shares of AstraZeneca worth $23.1K as of Q2 2026.
- Itau Unibanco Holding S.A. sold 58 AstraZeneca shares in Q2 2026, an estimated $10.9K.
- AstraZeneca made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #313 holding.
- Itau Unibanco Holding S.A. first reported a position in AstraZeneca in Q1 2017 and has held it in 35 quarters since.
- Itau Unibanco Holding S.A.'s AstraZeneca position peaked at $5.17M in Q2 2022.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.